Ewing sarcoma is an aggressive childhood cancer that is particularly difficult to treat, and little progress has been made in developing effective therapies for patients…
Read MoreToday, more than 80% of children diagnosed with cancer are alive 5 years after treatment. This is one of the biggest successes of pediatric medicine…
Read MoreWhen you have cancer, your body needs proper nutrients and calories to recover from treatment. Yet, eating well can be difficult when you feel nauseous…
Read MoreOn December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adult and pediatric patients 2 years of age and…
Read MoreThe Paula Takacs Foundation is proud to announce its 2022 sarcoma research grant in the amount of $275,000 to Levine Cancer Institute and Levine Children’s…
Read More